South Carolina Multistate Pharmacy Jurisprudence Examination (MPJE) Practice Exam

What is required for transferring C2 substances between pharmacies?

1. DEA form 224

2. DEA form 222

3. DEA form 91

4. No documentation required

The correct answer is: DEA form 222

The transfer of C2 substances between pharmacies must be documented using a DEA form 222. This form is specifically designed for the ordering and transferring of Schedule II controlled substances and is a necessary part of the regulatory framework established by the Drug Enforcement Administration (DEA). When one pharmacy transfers C2 substances to another, the originating pharmacy completes this form to indicate the transfer and to maintain accurate records concerning the distribution of controlled substances. The need for documentation is critical, as it helps ensure accountability and traceability of controlled substances throughout the supply chain, thus minimizing the risk of diversion and misuse. Using form 222 ensures that both pharmacies keep proper records for compliance with federal law, which is particularly stringent regarding Schedule II medications. This documentation process plays a vital role in maintaining an effective monitoring system. The other forms mentioned, such as DEA form 224 and DEA form 91, do not serve the purpose of transferring C2 substances: form 224 is for registering with the DEA to prescribe or dispense controlled substances, while form 91 is not relevant to the transfer process. The idea that no documentation is required is not in alignment with DEA regulations, which mandate rigorous record-keeping for controlled substances.